ipamorelin cjc 1295 without dac CJC-1295 No + Blend Research Vial Ipamorelin/CJC-1295 (no DAC) 5MG/5MG |

Our friendly, knowledgeable staff can answer all of your questions and help schedule a convenient appointment with one of our specialists

This pen is capable of dispensing precise doses of 0.25 mg, 0.5 mg, 0.75 mg, or 1 mg (delivering equal parts of each peptide per dose) for flexible administration based on research or practitioner instruction

It is a GHRH analog, FDA-approved as Egrifta, and in its trials it reliably raised IGF-1 and dropped visceral fat in people (Falutz, NEJM 2007)

Reported tolerability in the available human observational work is high: no consistent pattern of adverse effects has been published, although the absence of placebo-controlled trials means subtle effects cannot be excluded